DelveInsight’s, “Adeno-Associated Virus (AAV) Vectors in Gene Therapy Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Adeno-Associated Virus (AAV) Vectors in Gene Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Neurofibromatosis Type 2 pipeline constitutes 5+ key companies continuously working towards developing 5+ Neurofibromatosis Type 2 treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Neurofibromatosis Type 2 Pipeline Insight, 2025“ report by DelveInsight outlines comprehensive […]
DelveInsight’s, “Glioma Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Glioma pipeline landscape. It covers the Glioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Glioma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Non-Small Cell Lung Cancer pipeline constitutes 100+ key companies continuously working towards developing 120+ Non-Small Cell Lung Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Non-Small Cell Lung Cancer Pipeline Insight, 2025“ report by […]
The Key Epilepsy Companies in the market include – Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical, Angelini Pharma/Ono Pharmaceutical, Novartis, Xenon Pharmaceuticals, Takeda, Ovid Therapeutics, Biohaven Pharmaceuticals/Knopp Biosciences, and others. DelveInsight’s “Epilepsy Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hemophilia B pipeline constitutes 15+ key companies continuously working towards developing 20+ Hemophilia B treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Hemophilia B Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the […]
The Key Ichthyosis Companies in the market include – Krystal Biotech, GSK, Timber Pharmcecuticals, Janssen Scientific, Patagonia Pharma, Timber Pharmcuticals, Crown Laboratories, Inc, and others. DelveInsight’s “Ichthyosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Ichthyosis, historical and forecasted epidemiology as well as the Ichthyosis market trends in the […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Macular Telangiectasia pipeline constitutes 4+ key companies continuously working towards developing 4+ Macular Telangiectasia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Macular Telangiectasia Pipeline Insight, 2025“ report by DelveInsight outlines comprehensive insights into the […]
The Key Severe Atopic Dermatitis Companies in the market include – Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries Limited, Brickell Biotech Inc,, AstraZeneca, Kyowa Kirin, UCB Biopharma, Vanda Pharmaceuticals, Kyowa Kirin, Sanofi, KeyMed Biosciences, Asana BioSciences, Bristol-Myers Squibb, RAPT Therapeutics, Allakos, Novartis, BioMimetix, Shanghai Hengrui Pharmaceutical Co, Connect Biopharma, Pfizer, […]
DelveInsight’s, “Multiple Myeloma Pipeline Insights” report provides comprehensive insights about 75+ Multiple Myeloma Companies and 80+ pipeline drugs in the Multiple Myeloma pipeline landscape. It covers the Multiple Myeloma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Multiple Myeloma therapeutics assessment by product type, stage, route of administration, and molecule […]
